03/12/2025
🚨 Exciting News from MuriPhys! 🚨
MuriPhys received its radioactive materials license, expanding the scope of preclinical research that the team can discuss with sponsors.
Discuss radiolabeled drug development, biodistribution and oncology research with our scientists. The radionuclide, procedures, study endpoints and permitted activities are reviewed for the proposed scope.
Contact our team to discuss the radiopharmaceutical research question, materials, methods and timing.
Explore a study-specific collaboration with MuriPhys.